International Business Machines Corporation

New York Stock Exchange
Back to all articles
Bullish +65

17,415 Shares in International Business Machines Corporation $IBM ...

📈 Counterpoint Mutual Funds LLC purchased 17,415 shares of IBM valued at approximately $4.22 million in the first quarter.

🏦 Multiple hedge funds and institutional investors established new positions in Q3 and Q4 with valuations between $25,000 and $28,000.

💰 IBM increased its quarterly dividend to $1.69 per share, offering a 2.3% annualized yield to shareholders.

📊 The company maintains a market capitalization of $271.58 billion with a P/E ratio of 25.55.

🔼 Jefferies Financial Group initiated coverage on IBM with a 'buy' rating and strong analyst consensus.

🚀 JPMorgan Chase upgraded IBM to 'overweight' and raised its price target from $270.00 to $291.00.

📉 HSBC upgraded the stock from 'reduce' to 'hold' while increasing its price objective to $231.00.

🎯 The consensus analyst price target for IBM is currently set at $306.76.

Bullish Signals
  • Counterpoint Mutual Funds LLC acquired a significant new stake of 17,415 shares valued at $4.22 million in the first quarter.
  • Multiple institutional investors including Basepoint Wealth LLC and Joseph Group Capital Management initiated new positions totaling over $100,000 combined.
  • IBM raised its quarterly dividend to $1.69 per share, increasing the annualized yield to 2.3%.
  • Jefferies Financial Group initiated coverage with a 'buy' rating on IBM stock.
  • JPMorgan Chase upgraded IBM from 'neutral' to 'overweight' and increased its price target to $291.00.
  • HSBC upgraded IBM from 'reduce' to 'hold' and raised its price objective to $231.00.
  • The consensus analyst rating is 'Moderate Buy' with a collective price target of $306.76.
Risk Factors
  • BMO Capital Markets decreased its price target on IBM from $290.00 to $270.00 and assigned a 'market perform' rating.
  • Susquehanna assumed coverage with a 'neutral' rating, indicating no immediate bullish sentiment from this firm.
Full Analysis
Counterpoint Mutual Funds LLC increased its stake in International Business Machines Corporation (IBM) by purchasing 17,415 shares valued at approximately $4.22 million during the first quarter, according to recent SEC 13F filings. Several other institutional investors, including Basepoint Wealth LLC and Family CFO Inc, also established new positions in the fourth quarter with valuations ranging from $25,000 to $28,000 each. Institutional ownership of IBM stock currently stands at 58.96%. IBM's financial metrics show a market capitalization of $271.58 billion, a price-to-earnings ratio of 25.55, and a beta of 0.68. The company recently increased its quarterly dividend to $1.69 per share, paid on June 10th to shareholders of record as of May 8th, resulting in an annualized yield of 2.3% and a payout ratio of 59.77%. Balance sheet data indicates a debt-to-equity ratio of 1.75. Analyst sentiment has shifted positively with recent upgrades from major brokerages. Jefferies Financial Group initiated coverage with a 'buy' rating, while JPMorgan Chase upgraded the stock to 'overweight' and raised its price target to $291.00. HSBC also upgraded IBM from 'reduce' to 'hold' with a higher price objective. The consensus rating remains 'Moderate Buy' with an average price target of $306.76.